Literature DB >> 2317854

"High-risk" percutaneous transluminal coronary angioplasty with preventive intra-aortic balloon counterpulsation.

V Voudris1, J Marco, M C Morice, J Fajadet, T Royer.   

Abstract

Between January 1987 and February 1988, 1,385 patients underwent percutaneous transluminal coronary angioplasty; 27 procedures were performed using prophylactic intraaortic balloon counterpulsation. Twenty-four patients had poor left ventricular function (EF less than 40%), and coronary dilatation was performed in arteries opposite to an occluded myocardial necrosis related vessel. In three patients of advanced age with distal stenoses and normal left ventricular function a multivessel dilatation was performed. Primary success rate was achieved in all patients. There were no deaths, myocardial infarctions or emergency bypass operations in the hospitalization period. During the follow-up (9 to 21 months) there were 2 deaths, 1 cardiac transplantation, and 6 restenosis with repeated dilatation. If revascularization is warranted, in high-risk patients, coronary angioplasty can be performed safely and successfully with protection by intraaortic balloon counterpulsation. However the long-term prognosis of these patients is complicated by the presence of other high-risk variables, such as advanced age or poor left ventricular function.

Entities:  

Mesh:

Year:  1990        PMID: 2317854     DOI: 10.1002/ccd.1810190303

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  3 in total

1.  Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the National Cardiovascular Data Registry.

Authors:  Jeptha P Curtis; Saif S Rathore; Yongfei Wang; Jersey Chen; Brahmajee K Nallamothu; Harlan M Krumholz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-12-06

2.  Myocardial protection during coronary angioplasty.

Authors:  P Angelini; D R Leachman; G Disciascio; M J Cowley; J A Brinker
Journal:  Tex Heart Inst J       Date:  1992

3.  Percutaneous Hemodynamic Support in PCI.

Authors:  Jason Hatch; Dmitri Baklanov
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.